ArticleThe Journal of clinical investigation1998

Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.

V P Khatri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.